Cargando…

Marizomib: A novel therapeutic approach for the treatment of central nervous system myeloma

Detalles Bibliográficos
Autores principales:	Bazou, Despina, Le, Giao, Boyle, Aoife, Blum, Agnieszka, O'Gorman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175806/ https://www.ncbi.nlm.nih.gov/pubmed/35847709 http://dx.doi.org/10.1002/jha2.72

Ejemplares similares

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
por: Blum, Agnieszka, et al.
Publicado: (2018)

Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach
por: Katsenou, Angeliki, et al.
Publicado: (2023)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
por: Tierney, Ciara, et al.
Publicado: (2021)

Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients
por: Ting, Kay Reen, et al.
Publicado: (2017)

Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers
por: Dunphy, Katie, et al.
Publicado: (2021)

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
por: Levin, Nancy, et al.
Publicado: (2016)

Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures
por: Dunphy, Katie, et al.
Publicado: (2023)

Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo
por: Manton, Christa A., et al.
Publicado: (2016)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
por: Raninga, Prahlad V., et al.
Publicado: (2020)

Bleeding and Thrombosis in Multiple Myeloma: Platelets as Key Players during Cell Interactions and Potential Use as Drug Delivery Systems
por: Kulkarni, Anushka, et al.
Publicado: (2023)

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data
por: Bota, Daniela A, et al.
Publicado: (2021)

Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
por: Boccellato, Chiara, et al.
Publicado: (2021)

Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas
por: Jane, Esther P., et al.
Publicado: (2023)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Multiple myeloma with central nervous system relapse
por: Egan, Philip A., et al.
Publicado: (2020)

Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo
por: Zhang, Ziruizhuo, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
por: German, Nadezhda A.
Publicado: (2023)

Generating a Generation of Proteasome Inhibitors: From Microbial Fermentation to Total Synthesis of Salinosporamide A (Marizomib) and Other Salinosporamides
por: Potts, Barbara C., et al.
Publicado: (2010)

The New Therapeutics
por: O'Gorman, P. W.
Publicado: (1902)

The New Therapeutics
por: O'Gorman, P. W.
Publicado: (1901)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

Metabolomics in the identification of biomarkers of dietary intake
por: O'Gorman, Aoife, et al.
Publicado: (2013)

Multiple myeloma with simultaneous cutaneous and central nervous system involvement
por: Nguyen, James, et al.
Publicado: (2018)

Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies
por: Wnuk, Agnieszka, et al.
Publicado: (2023)

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature
por: Varga, Gergely, et al.
Publicado: (2018)

Multiple Myeloma: A Review of Imaging Features and Radiological Techniques
por: Healy, C. F., et al.
Publicado: (2011)

Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
por: Panzarini, Elisa, et al.
Publicado: (2020)

Irish Roma: a literature review
por: O’Sullivan, Aoife, et al.
Publicado: (2022)

Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report
por: Waterhouse, Deirdre F, et al.
Publicado: (2009)

Review: Central nervous system involvement in mitochondrial disease
por: Lax, N. Z., et al.
Publicado: (2016)

Multiple myeloma and central nervous system involvement: experience of a Brazilian center
por: Dias, Ana Luiza Miranda Silva, et al.
Publicado: (2018)

Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system
por: Murase, Takayuki, et al.
Publicado: (2019)

IgG kappa multiple myeloma with isolated central nervous system relapse
por: Xu, Ke, et al.
Publicado: (2022)

ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
por: Movia, Dania, et al.
Publicado: (2019)

Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
por: Bobin, Arthur, et al.
Publicado: (2020)

Targeting IL-17A in Multiple Myeloma: A Potential Novel Therapeutic Approach in Myeloma
por: Prabhala, Rao H., et al.
Publicado: (2015)

Novel approaches and challenges to treatment of central nervous system viral infections
por: Nath, Avindra, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k9k5a9bfk3ephjbu4h9dib441e